Business
from24/7 Wall St.
2 days agoWhat Smart Money Loves About Lilly
Eli Lilly delivered consecutive blowout quarters with strong revenue and earnings beats, driven by Mounjaro and Zepbound dominance, while institutional investors accumulate shares despite a year-to-date pullback.